Skip to main content
Back to DCVC

DCVC's Biotechnology Portfolio

Browse 46 Biotechnology companies funded by DCVC. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
46
Total Funding in Biotechnology
$2.5B

Biotechnology Portfolio Companies (46)

Export
BiopharmaBiotechnologyTherapeutics

Novome Biotechnologies is a biotechnology company focused on engineering defined activities into the human.

South San Francisco, United States
September 2022
$43.5M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyGeneticsHealth Care

Molecular Assemblies is developing a revolutionary, enzymatic DNA synthesis technology capable of powering new products.

San Diego, United States
August 2024
$4.0M
Grant

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics

Plexium develops a targeted protein degradation platform to find new therapies for cancer and other diseases.

San Diego, United States
August 2025
$60.1M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyMedicalPharmaceutical

Alchemab Therapeutics is developing protective antibodies designed to keep people free of hard-to-treat diseases.

London, United Kingdom
July 2026
$33.6M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyManufacturingProduct ResearchSustainability

MycoWorks is a biotechnology company that offers non-plastic and non-animal materials to the market.

Emeryville, United States
July 2024
Series D

Founder Contacts

41,000+ verified contacts

AgricultureAgTechBiotechnologyCleanTech

Pivot Bio is an agricultural tech company improving the microbiome by taking nitrogen from the air and making it available for plants.

Berkeley, United States
July 2021
$430.0M
Series D

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Auron aims to cure cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells.

Newton, United States
July 2025
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyTherapeutics

Stemson Therapeutics is a pre-clinical stage cell therapy company.

San Diego, United States
July 2021
$15.0M
Series A

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyLife SciencePharmaceuticalPrecision MedicineTherapeutics

Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines.

San Francisco, United States
June 2024
$20.0M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyMedicalProduct ResearchTherapeutics

Syntax Bio is a biotechnology company that develops a cell programming platform to control stem cell differentiation for research.

Chicago, United States
June 2026
$14.4M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyLife Science

Mapping interactions foundational to therapeutic discovery and human health.

Monmouth Junction, United States
May 2026
$48.0M
Series A

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyGeneticsTherapeutics

Latus Bio develops gene therapy candidates, particularly for treating central nervous system (CNS) disorders using screened AAV capsids.

Philadelphia, United States
May 2026
$43.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyMedicalTherapeutics

AbCellera is an antibody discovery and development company that develops antibody therapeutics to improve patient outcomes.

Vancouver, Canada
May 2023
$515.8M
Grant

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CareHealth Diagnostics

Karius delivers genomic insights into infectious diseases, helping clinicians make critical, life-saving treatment decisions.

Redwood City, United States
May 2024
$100.0M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Sidewinder Therapeutics is a biotechnology company that offers life-saving therapies for cancer and rare diseases.

San Diego, United States
April 2026
$137.0M
Series B

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyGeneticsHealth CareLife Science

Deepcell is a life science company specializing in AI-powered single-cell classification and isolation for basic and translational research.

Menlo Park, United States
April 2025
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

AnalyticsBiotechnologyClinical TrialsMedical

Grove Biopharma is a biotechnology company offering a materials science solution to peptide therapeutic challenges.

Chicago, United States
April 2025
$30.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyLife Science

Reinventing drug development from the ground up to make safe, effective oligonucleotide-based medicines possible on demand.

San Diego, United States
March 2022
$40.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceMedical

Empirico is a developer of an insights platform designed to turn biological insights from human genetics into new medicines.

San Diego, United States
March 2023
$45.2M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyConsultingManufacturingTherapeutics

Ascend Gene & Cell Therapies is a model for gene and cell therapy manufacturing.

Potters Bar, United Kingdom
March 2023
$65.9M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareHealth Diagnostics

Lucira Health is a biotechnology company that offers disposable test kits to detect RNA and DNA of infectious diseases.

Emeryville, United States
February 2022
$80.0M
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

BiotechnologyMedicalTherapeutics

Chroma Medicine is a biotechnology company that develops genetic medicines for the treatment of genetic disorders.

Cambridge, United States
February 2023
$135.0M
Series B

Founder Contacts

41,000+ verified contacts

3D TechnologyBiotechnologyFood and BeverageFood Processing

ENOUGH is a food ingredient company that specializes in using the natural process of fermentation.

Glasgow, United Kingdom
February 2024
Series C

Founder Contacts

41,000+ verified contacts

AnalyticsArtificial Intelligence (AI)Big DataBiotechnologyHealth CareInformation ServicesWater

A wastewater data platform delivering population-level health insights

Cambridge, United States
June 2025
$13.4M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyMedicalTherapeutics

Solu Therapeutics Platform Company that develops antibody-based medicines using a degradable warhead.

Boston, United States
April 2025
$41.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyNeuroscience

Newleos Therapeutics is a biotech startup dedicated to producing safer and more effective neuroscience medicines.

Boston, United States
February 2025
$93.5M
Series A

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyGeneticsHealth Care

Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases.

Cambridge, United States
April 2024
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyGeneticsPharmaceuticalTherapeutics

GenEdit develops next generation therapeutics for genetic diseases through safe and efficient CRISPR/Cas9 delivery.

South San Francisco, United States
January 2024
$24.0M
Series A

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyMedical

Totus Medicines employs uses AI/ML and innovative DNA-encoded covalent library tech to discover small molecule medicines.

Cambridge, United States
December 2023
$66.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyClinical TrialsGeneticsHealth CareHealth DiagnosticsPrecision Medicine

Cofactor Genomics builds multidimensional models of disease to deliver true precision medicine.

San Francisco, United States
August 2023
$1.2M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceMedical

ShennonBio analyzes and manipulates a massive number of cells on the single cell level to develop better treatments for human diseases.

San Francisco, United States
March 2023
$13.0M
Seed

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyLife Science

Evonetix is a provider of a desktop platform designed to synthesize DNA at unprecedented accuracy and scale.

Little Chesterford, United Kingdom
February 2023
$24.1M
Series B

Founder Contacts

41,000+ verified contacts

AgricultureAgTechBiotechnologyCleanTechFarming

Entocycle develops the technology to enable efficient and scalable insect farming.

London, United Kingdom
January 2023
$5.0M
Series A

Founder Contacts

41,000+ verified contacts

AnalyticsArtificial Intelligence (AI)BiotechnologyHealth CareImage RecognitionMachine LearningMedical DeviceNatural Language ProcessingPredictive AnalyticsSoftware

Enlitic builds AI deep learning products to streamline radiologists' workflows and improve healthcare diagnosis.

Fort Collins, United States
December 2025
$7.1M
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife SciencePharmaceutical

Superfluid Dx is a biotechnology company developing novel blood-based early detection.

San Diego, United States
December 2023
Series A

Founder Contacts

41,000+ verified contacts

AgricultureAquacultureBiotechnology

CH4 Global mission is to use sustainable aquaculture to impact climate change at scale.

Henderson, United States
January 2025
Corporate Round

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyManufacturingMedical

Umoja Biopharma is a biopharmaceutical company developing next-generation immunotherapies intended to combat cancer.

Seattle, United States
January 2025
$100.0M
Series C

Founder Contacts

41,000+ verified contacts

Alternative MedicineArtificial Intelligence (AI)BiotechnologyClinical TrialsLife ScienceMachine Learning

Proxima Bio develops programmable medicines that modulate protein interactions to address disease processes.

New York, United States
January 2026
$91.5M
Seed

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeuticsWellness

NILO Therapeutics is a biotechnology and therapeutics company.

New York, United States
October 2025
$101.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyGeneticsHealth CareMedical

Relation Therapeutics is a biotechnology company that focuses on humanizing drug discovery and development.

London, United Kingdom
December 2025
$26.0M
Series Unknown

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyLife Science

Noetik is an AI-native biotechnology company that applies machine learning to large-scale human multimodal spatial omics datasets.

South San Francisco, United States
September 2024
$1.0M
Grant

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CarePharmaceuticalTherapeutics

A clinical stage drug development company who aims to invent novel drugs for hard-to-treat diseases using its proprietary AI platform

Palo Alto, United States
August 2020
$15.7M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareSoftware

BrainSpec is a health-tech company that enables accurate, efficient, and non-invasive diagnosis of brain disorders.

Boston, United States
April 2020
$31K
Debt Financing

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

Macromoltek does computational drug discovery for pharma companies, focusing on antibodies for therapeutics and diagnostics.

Austin, United States
January 2018
$120K
Seed

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMedical DeviceTherapeutics

Agenovir is developing novel antiviral therapeutics for diseases associated with viral reservoirs

San Diego, United States
May 2016
$10.6M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Capella Bioscience engages in the discovery and development of monoclonal antibodies.

London, United Kingdom
March 2016
$15.5M
Series A

Founder Contacts

41,000+ verified contacts

Explore DCVC's Full Portfolio

View all companies funded by DCVC across every industry and funding stage.

View Full DCVC Portfolio